Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia

Cancer

Volumn 79, Issue 5, 1997, Pages 1049-1054

  Sandler, Eric S ^a,d   Friedman, David J ^b   Mustafa, Mahmoud M ^c   Winick, Naomi J ^a   Bowman, W Paul ^b   Buchanan, George R ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Cook Children's Medical Center ^*  (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

bone marrow transplantation; epipodophyllotoxin; etoposide; secondary leukemia

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; MITOXANTRONE; PREDNISONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DRUG INDUCED CANCER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, MYELOID; MALE; NEOPLASMS, SECOND PRIMARY; PODOPHYLLOTOXIN; SURVIVAL ANALYSIS;

EID: 0031040088     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970301)79:5<1049::AID-CNCR24>3.0.CO;2-0     Document Type: Article

References (37)

1. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, et al. Therapy related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood 1991;78:2982-8.
2. Detourmignies L, Castaigne S, Stoppa AM, Harousseau TL, Sadoun A, Janvier M, et al. Therapy related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol 1992; 10:1430-5.
3. Heyn R, Haeberlen V, Newton WA, Ragab AH, Raney RB, Tefft M, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 1993;11:262-70.
4. Sandoval C, Pui CH, Bowman LC, Heaton D, Hurwitz CA, Raimondi SC, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors and irradiation. J Clin Oncol 1993;11:1039-5.
5. Abrahamsen JF, Andersen A, Hannisdal E, Nome O, Abrahamsen AF, Kvaloy S, et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment follow-up time and age. J Clin Oncol 1993;11:255-61.
6. Hoppe RT. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease. Leukemia 1992;6(Suppl 4):155-7.
7. Carbone P, Santoro A, Giglio MC, Mirto S, Granata G, Barbata G. Cytogenetic findings in secondary acute non-lymphocytic leukemia. Cancer Genet Cytogenet 1992;58:18-23.
8. Green DM, Zevon MA, Reese PA, Lowrie GS, Gaeta JF, Pearce JI, et al. Second malignant tumors following treatment during childhood and adolescents for cancer. Med Pediatr Oncol 1994;22:1-10.
9. Preisler HD, Early AP, Raza A, Vlahides G, Marinello MJ, Stein AM, et al. Therapy of secondary acute non-lymphocytic leukemia with cytarabine. N Engl J Med 1983;308:21-3.
10. DeWitte T, Muus P, DePauw B, Haanen C. Intensive anti-leukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990;66:831-7.
11. Hoyle CF, de Bastos M, Wheatley K, Sherrington PD, Fischer PJ, Rees JK, et al. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders. Br J Haematol 1989;72:45-9.
12. Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Walker I, et al. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia. J Clin Oncol 1987;5:75-82.
13. Ballen KK, Antin JH. Treatment of therapy related acute myelogenous leukemia and myelodysplastic syndromes. Hematol Oncol Clin North Am 1993;7:477-93.
14. Sutton L, Leblond V, LeMaignan C, Jouet JP, Kuentz M, Gluckman E, et al. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplant 1991;7 (Suppl 2):39.
15. De Witte T, Hermans J, van Biezen J, Vernant J, Kolb H, Zwaan F, et al. Prognostic variables in bone marrow transplantation for secondary leukemia and myelodysplastic syndrome: a survey of the working party on leukemia. Bone Marrow Transplant 1991;7 (Suppl 2):40.
16. Verdeguer A, Ruiz JG, Ferris J, Esquembre C, Tasso MJ, Fernandez JM, et al. Acute non-lymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide. Med Pediatr Oncol 1992;20:48-52.
17. Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, et al. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cis-platinum or cyclophosphamide for breast cancer. J Clin Oncol 1992;10:1444-51.
18. Donatini B, Krupp P. Secondary pre-leukemia and etoposide. Lancet 1991;338:1269.
19. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-7.
20. Pui CH, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989; 321:136-42.
21. Kreissman SG, Gelber RD, Cohen HG, Clavell LA, Leavitt P, Sallan SE. Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia. Cancer 1992;70:2208-13.
22. Smith MA, Rubinstein L, Cazenave L, Ungerleider RS, Maurer HM, Heyn R, et al. Report of the cancer therapy evaluation program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins. J Natl Cancer Inst 1993;85:554-8.
23. Winick N, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 1993;11:209-17.
24. Winick N, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, et al. Unexpected neurotoxicity in children with acute lymphoblastic leukemia receiving divided dose oral methotrexate. J Natl Cancer Inst 1992;84:252-6.
25. Winick N, Bowman WP, Shuster JJ, Bowman WP, Borowitz M, Farrow A, et al. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B precursor acute lymphocytic leukemia. J Clin Oncol 1996;14:2803-11.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1985;53:457-81.
27. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
28. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ryman FB, et al. Second neoplasm after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-6.
29. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991;337:61-6.
30. Rivera GK, Pui CH, Santana VM, Pratt CB, Grist WM. Epipodophyllotoxins in the treatment of childhood cancer. Cancer Chemother Pharmacol 1994;34:589-95.
31. Sugita K, Furukawa T, Tsuchida M, Okawa Y, Nakazawa S, Akatsuka J, et al. High incidence of etoposide-related secondary leukemia in children with non-Hodgkin's lymphoma. Am J Pediatr Hematol Oncol 1993;15:99-104.
32. Zulian GB, Jotterand Bellom M, Cabrol L, Beris P, Mermillod B, Alberto P. Etoposide and secondary haematological malignancies: coincidence or casualty? Ann Oncol 1993;4:559-66.
33. Pui CH, Relling MV, Behm FG, Hancock ML, Boyett JM, Raimondi SC, et al. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia 1995; 9:1680-4.
34. Sandoval C, Head DR, Mirro J, Behm FG, Ayers GO, Raimondi SC. Translocation t(9;11) (p21;q23) in pediatric denovo and secondary acute myeloblastic leukemia. Leukemia 1992;6:513-9.
35. Pui CH, Relling MV, Rivera GK, Hancock ML, Raimondi SC, Heslop HE, et al. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 1995;9:1990-6.
36. Longmore G, Guinan EC, Weinstein HJ, Gelber RD, Rappeport JM, Antin JH. Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. J Clin Oncol 1990;8:1707-14.
37. Lauer SJ, Toledano S, Winick N, Munoz L, Mahoney D, Pullen J, et al. A comparison of early intensive methotrexate/ mercaptopurine vs. early intensive alternating chemotherapy for high risk acute lymphoblastic leukemia: a Pediatric Oncology Group randomized phase III study [abstract]. Proc Annu Meet Am Soc Clin Oncol 1995;14:342.